ClinConnect ClinConnect Logo
Search / Trial NCT03513575

Comparison of 5 Buffering Agents on Changes in Salivary pH in Individuals Previously Exposed to a Test Flavoured Milk

Launched by DR MERU S · Apr 30, 2018

Trial Information

Current as of June 04, 2025

Completed

Keywords

P H Of Saliva Flavored Milk Buffering Agent Oral Hygiene

ClinConnect Summary

There are substantial existing evidences that there is diurnal variation in the flow of saliva and hence the composition of saliva. The average of normal pH of saliva is reported to be 6.8. Consumption of most types of acidic and sweetened foods and beverages are known to reduce the pH of saliva and some of them even reduce it to critical pH levels and result in structural damage to the hard tissues of the tooth.

Such damages can be prevented by maintaining the pH of saliva within optimal range by using oral hygiene measures.

The purpose of this study is to ascertain the effect of the sel...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • subjects in the age group of 18 to 30 years.
  • subjects with a DMFT index score of less than 2.
  • subjects with Loe and Silness index score of 0.
  • subjects willing to volunteer for the study.
  • subjects who are available for the whole study period of 4 months
  • Exclusion Criteria:
  • subjects with history of gastritis and bulimia.
  • subjects with chronic medical illness.
  • subjects with history of allergy.
  • subjects with history of drug intake for last 8 weeks.
  • subjects who smoke or chew tobacco.

About Dr Meru S

Dr. Meru S. is a leading clinical trial sponsor dedicated to advancing medical research and innovation. With a commitment to enhancing patient care, Dr. Meru S. collaborates with healthcare professionals, research institutions, and pharmaceutical companies to design and implement rigorous clinical trials. The organization focuses on a diverse range of therapeutic areas, aiming to bring new treatments to market while ensuring the highest standards of ethical conduct and patient safety. Through its comprehensive approach to clinical development, Dr. Meru S. strives to accelerate the translation of scientific discoveries into effective healthcare solutions.

Locations

Dehradun, Uttarakhand, India

Patients applied

0 patients applied

Trial Officials

Meru S, MDS

Principal Investigator

Uttaranchal Dental & Medical Research Institute

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials